Patent directory · USPTO A61K / A61P
Patents matching “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE”
783 pharma patents match "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 783 pharmaceutical patents matching "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10166244
Targeting NCCA-ATP channel for organ protection following ischemic episode
granted -
US 10143721
Combination product for the prevention of sexually transmitted infections
granted -
US 10137188
Cell lines for virus production and methods of use
granted -
US 10137136
Methods for inhibiting muscle atrophy
granted -
US 10124043
Mutant OPAA enzymes with increased catalytic efficiency on organophosphorus compound EA1356
granted -
US 10093710
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia
granted -
US 10092637
Dengue virus E-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes
granted -
US 10081658
Truncated HIV envelope proteins (ENV), methods and compositions related thereto
granted -
US 10081659
Adeno-associated vectors for enhanced transduction and reduced immunogenicity
granted -
US 10081669
Therapy for filovirus infection
granted -
US 10077446
Glucan-encapsulated siRNA for treating type 2 diabetes mellitus
granted -
US 10072084
Dual specific immunotoxin for brain tumor therapy
granted -
US 10064933
Recombinant rift valley fever (RVF) viruses and methods of use
granted -
US 10064858
Methods and compositions for treating bacterial infections with iron chelators
granted -
US 10053514
Human bispecific EGFRvIII and CD3 antibody engaging molecules
granted -
US 10052374
Compositions, methods and uses for dengue virus serotype-4 constructs
granted -
US 10052382
Methods for using antibodies for 3′ iso-LM1 and 3′, 6′-iso-LD1tumor gangliosides
granted -
US 10040830
Methods and compositions for protein delivery
granted -
US 10039741
Use of delta tocopherol for the treatment of lysosomal storage disorders
granted -
US 10040826
Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens
granted -
US 10034936
Method of inducing a cross-reactive HIV-1 immune response by administering a composition comprising the GBV-C E2 protein
granted -
US 10016480
Peptide-based methods for treating pancreatic cancer
granted -
US 10004800
Antibody evolution immunogens
granted -
US 10000556
Single-domain VHH antibodies directed to norovirus GI.1 and GII.4 and their use
granted